Advertisement China GLP-1 drug study suggests slim chance weight stays off after treatment Significant weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations 2-MIN READ2-MIN 1 A Chinese analysis of prescription anti-obesity medications has added to evidence that people who use popular GLP-1 drugs such as Ozempic to shed pounds face the prospect of significant weight rebound once they stop using them challenges similar to those presented by more traditional slimming strategies
But some feedback also mentions common problems, like treatment discontinuation
The company also continued to sell personalized doses of semaglutide "for the subset of consumers for whom it is a clinical necessity," Dudum said
Morgan & Morgan is Americas largest injury law firm, with a proven track record in holding pharmaceutical companies accountable
Programs like TrimRX offer valuable support, including personalized consultations, custom dosing plans for GLP-1 medications (like Semaglutide, Tirzepatide, Mounjaro, Zepbound, Wegovy, and Ozempic), and unlimited check-ins to adjust your strategy as needed